Further studies on the role of APP in the pathogenesis of AD and other neurodegenerative diseases using our new cellular model for intracellular tau accumulation in cells expressing APP may lead to the development of new therapies and pharmaceuticals for these diseases. This evidence concerns the gene MAPT and neurodegenerative disease.